Jane Street Group, LLC Satsuma Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$4.54 - $7.17 $87,426 - $138,072	-19,257 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.8 - $7.25 $33,211 - $50,162	6,919 Added 56.08%	19,257 $136,000
Q1 2021 May 18, 2021	BUY	$4.57 - $7.18 $56,384 - $88,586	12,338 New	12,338 $73,000
Q4 2020 Feb 17, 2021	SELL	$3.56 - $5.09 $69,918 - $99,967	-19,640 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$3.85 - $28.47 $75,614 - $559,150	19,640 New	19,640 $76,000

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.